CleverCare system's improving through the development of new features, adaptations for internationalization and development of new methodologies of access to the system

• Grant number: 16/00774-4
• Support Opportunities: Research Grants - Innovative Research in Small Business - PIPE
• Start date: April 01, 2017
• End date: December 31, 2017
• Field of knowledge: Physical Sciences and Mathematics - Computer Science - Computer Systems
• Principal Investigator: Hugo Cesar Pessotti
• Grantee: Hugo Cesar Pessotti
• Company: Kidopi Soluções em Informática Médica Ltda (Kidopi)
• City: Ribeirão Preto
• Associated research grant(s): 17/27251-4 - CleverCare system's improving through the development of new features, adaptations for internationalization and development of new methodologies of access to the system, AP.PIPE

Abstract

Kidopi has developed and markets CleverCare (www.CleverCare.com.br), a framework for control, management and guidance of patients who require continuous medical surveillance, which was elected by the United Nations (UN) as the best software in the domain of health at the World Summit Award (WSA) in 2015 (http://www.wsis-award.org/winners). In the national market, CleverCare has been used by the Albert Einstein Hospital, a reference hospital in health care, through an established technical and operational cooperation agreement to explore new scenarios of innovation and deployment. CleverCare is also at an advanced stage of implementation for hypertensive patients care at the Clinics Hospital of Ribeirão Preto of the University of São Paulo. In addition to graphical user interfaces and Application Programing Interfaces (APIs), CleverCare has a state machine, a dialog management system, natural language processing tools (NLP) and integration with messaging services like Telegram and SMS, which allow communication between patient and system in a personalized and active way, providing a close care. The goal of this project is to improve the natural language processing of CleverCare, including support for foreign languages, development of a Decision-Making module to improve the management of the dialogues and develop a new method of access through wearable devices, aiming to achieve more dynamism and effectiveness in monitoring the patient, as the patient's adherence to his treatment plan is essential to the successful outcome of his illness. The proposed innovations aim to enhance the innovative characteristics of CleverCare and prepare it for an international expansion phase, which is being planned through international missions in partnership with Anprotex, Apex and Redempreendia. With these improvements, it is expected that CleverCare will become more competitive in the national market, while also enabling its insertion in the international market and increase patient adhesion to his treatment plan. (AU)